QQ客服 官方微博 反馈留言

	Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine
	Hong, Yuan; Che, Shaomin; Hui, Beina; Yang, Yunyi; Wang, Xiaoli; Zhang, Xiaozhi; Qiang, Yongqian; Ma, Hailin
刊名	BIOMEDICINE & PHARMACOTHERAPY
	2019
卷号	112
关键词	Doxorubicin Curcumin Lung cancer pH sensitive Urokinase plasminogen activator receptor
ISSN号	0753-3322
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2827740
专题	西安交通大学
推荐引用方式 GB/T 7714	Hong, Yuan,Che, Shaomin,Hui, Beina,et al. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine[J]. BIOMEDICINE & PHARMACOTHERAPY,2019,112.
APA	Hong, Yuan.,Che, Shaomin.,Hui, Beina.,Yang, Yunyi.,Wang, Xiaoli.,...&Ma, Hailin.(2019).Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.BIOMEDICINE & PHARMACOTHERAPY,112.
MLA	Hong, Yuan,et al."Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine".BIOMEDICINE & PHARMACOTHERAPY 112(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。